Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2.
Related Article(s):
Genetic Variants of SARS-CoV-2—What Do They Mean?
Next-Generation Sequencing of Infectious Pathogens
Next Generation Sequencing of Infectious Pathogens in Public Health and Clinical Practice
